US2020107881A1PendingUtilityA1

Methods and systems for blocking neural activity in an organ of a subject, preferably in the small intestine or the duodenum

Assignee: DIGMA MEDICAL LTDPriority: Apr 17, 2014Filed: Dec 9, 2019Published: Apr 9, 2020
Est. expiryApr 17, 2034(~7.7 yrs left)· nominal 20-yr term from priority
A61B 2018/2277A61B 5/0066A61B 2090/061A61B 5/026A61B 2018/00744A61B 2018/00982A61B 2018/20359A61N 2007/0052A61B 2018/00809A61B 8/445A61N 2005/063A61B 2018/00714A61B 2018/00785A61B 6/00A61B 2218/001A61B 2018/00285A61B 1/012A61B 2090/378A61B 2018/00577A61B 18/26A61B 2018/00601A61B 8/12A61B 2018/00029A61B 2018/2266A61B 2018/00494A61B 18/02A61B 2018/00779A61B 5/015A61B 2018/2261A61B 2018/00589A61N 2007/0043A61B 2090/3735A61N 2007/003A61B 5/0086A61B 2018/00434A61B 2505/05A61B 18/22A61B 2018/00904A61B 8/085A61N 7/00A61B 2018/00273A61B 2018/20355A61N 2005/0659A61B 2018/00702A61N 5/0603A61N 5/062A61B 5/1076A61N 5/0625A61B 2018/2283A61B 5/4255A61B 2018/0212A61B 5/055
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides, according to some embodiments, methods and systems for selectively reducing, blocking or inhibiting at least part of the neural activity in an organ of a subject. In preferred embodiments, the method and system are used for selectively blocking at least part of the neural activity in a duodenum of a subject in need thereof. According to some embodiments, the selective blocking occurs through use of laser radiation. According to some embodiments, the selective blocking occurs through use of ultrasound energy. According to some embodiments, the selective blocking comprises causing damage to at least part of sensory nerves located within a target area while maintaining functional activity of tissue surrounding the sensory nerves by means of shielding it from the effects of laser radiation. According to some embodiments, the sensory nerves include neurons configured to transmit signals triggered by food passing through the duodenum, such as, but not limited to, neurohormonal signals.

Claims

exact text as granted — not AI-modified
1 .- 111 . (canceled) 
     
     
         112 . A method for reducing neural activity in a duodenum of a subject, the method comprising:
 introducing ultrasound transducer into the duodenum of the subject;   emitting a focused ultrasound beam at a frequency in a range of 5 MHz to 50 MHz and at an intensity of 5 to 300 Watt/cm 2  wherein the ultrasound beam is configured to be absorbed by different layers of the duodenum in the target area;   lowering a temperature of the target area utilizing a cooling mechanism, thereby causing selective ablation of sensory nerves located in the target area's submucosal layer to at least partially reduce the neural activity within the submucosal layer while maintaining functional activity of the mucosal layer within the treated target area and/or surrounding the treated target area.   
     
     
         113 . The method of  claim 112 , wherein the focused ultrasound beam emitted is selected from a high-intensity focused ultrasound (HIFU) beam, a microfocused ultrasound beam, a laser induced focused ultrasound (LGFU) beam or a focused ultrasound beam enhanced with micro-bubbles. 
     
     
         114 . The method of  claim 113 , wherein the focused ultrasound beam is a HIFU beam configured to generate thermal stress and/or cavitation that selectively disrupts or destroys the sensory nerves in the target area. 
     
     
         115 . The method of  claim 113 , wherein the HIFU beam causes the temperature of the sensory nerves to be raised and maintained at a temperature above about 42° C. 
     
     
         116 . The method of  claim 112 , wherein the ultrasound beam propagates radially in a circular range of 360 degrees around the ultrasound transducer. 
     
     
         117 . The method of  claim 112 , wherein the ultrasound transducer is configured to emit the ultrasound beam with an exposure in a range of 5-100 seconds. 
     
     
         118 . The method of  claim 117 , wherein the ultrasound transducer is configured to emit the ultrasound beam with an exposure of approximately 30 seconds. 
     
     
         119 . The method of  claim 118 , wherein the ultrasound transducer is configured to emit the ultrasound beam with an exposure of no more than 60 seconds. 
     
     
         120 . The method of  claim 112 , wherein the ultrasound transducer comprises an inflatable balloon configured to stretch a wall of the duodenum in the target area and to position the ultrasound transducer in the center of the duodenal lumen. 
     
     
         121 . The method of  claim 120 , wherein the inflatable balloon surrounds the ultrasound transducer and wherein the inflatable balloon is made of a martial configured to allow passage of the emitted ultrasound beam therethrough. 
     
     
         122 . The method of  claim 112 , further comprising introducing a heating mechanism configured to maintain and/or elevate a temperature of the duodenal wall to a 37° C. or above to increase impact of the ultrasound beam. 
     
     
         123 . The method of  claim 112 , wherein the focused ultrasound beam is emitted at a frequency in a range of 5 MHz to 20 MHz and at an intensity of 5 to 150 Watt/cm 2 . 
     
     
         124 . The method of  claim 112 , wherein the focused ultrasound beam is emitted at a frequency in a range of 10 MHz to 40 MHz wherein the focused ultrasound beam is emitted at an intensity of 5 to 80 Watt/cm 2 . 
     
     
         125 . The method of  claim 112 , further comprising emitting a second ultrasound beam configured for imaging of the target area. 
     
     
         126 . A method for reducing neural activity in a duodenum of a subject, the method comprising:
 introducing ultrasound transducer into the duodenum of the subject;   emitting a high-intensity focused ultrasound beam emitting a focused ultrasound beam at a frequency in a range of 1 MHz to 50 MHz and at an intensity of at least 500 Watt/cm 2  configured to configured to generate thermal stress and/or cavitation that selectively disrupts or destroys the sensory nerves in the target area, such that the neural activity within the submucosal layer is reduced while functional activity of the mucosal layer is maintained.   
     
     
         127 . The method of  claim 126 , wherein the HIFU beam causes the temperature of the sensory nerves to be raised and maintained at a temperature above about 42° C. 
     
     
         128 . The method of  claim 126 , wherein the circular ultrasound beam propagates radially in a circular range of 360 degrees around the ultrasound transducer. 
     
     
         129 . The method of  claim 126 , wherein the ultrasound transducer is configured to emit the ultrasound beam with an exposure in a range of 1-180 seconds. 
     
     
         130 . The method of  claim 126 , wherein the ultrasound transducer comprises an inflatable balloon configured to stretch a wall of the duodenum in the target area and to position the ultrasound transducer in the center of the duodenal lumen. 
     
     
         131 . The method of  claim 126 , further comprising emitting a second ultrasound beam configured for imaging of the target area.

Join the waitlist — get patent alerts

Track US2020107881A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.